Gestione nutrizionale degli individui con obesità e Covid-19: statements degli esperti ESPEN e raccomandazioni pratiche

2021-07-06T19:33:19+02:00

Contributo: Gortan Cappellari Gestione nutrizionale degli individui con obesità e Covid-19: statements degli esperti ESPEN e raccomandazioni pratiche Titolo tradotto Gestione nutrizionale degli individui con obesità e Covid-19: statements degli esperti

Gestione nutrizionale degli individui con obesità e Covid-19: statements degli esperti ESPEN e raccomandazioni pratiche2021-07-06T19:33:19+02:00

The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.

2020-04-29T22:18:00+02:00

Contributo di Stefania Camastra The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery. Martinussen C, Veedfald S, Dirksen C, Bojsen-Møller KN, Svane MS, Wewer

The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.2020-04-29T22:18:00+02:00

Il bypass gastrico determina cambiamenti precoci nella fisiologia del tessuto adiposo di soggetti obesi con diabete

2020-04-22T14:01:45+02:00

Contributo di Valeria Guglielmi High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Alta prevalenza di obesità nei soggetti con infezione da SARS-CoV-2 che necessitano ventilazione

Il bypass gastrico determina cambiamenti precoci nella fisiologia del tessuto adiposo di soggetti obesi con diabete2020-04-22T14:01:45+02:00

Il bypass gastrico determina cambiamenti precoci nella fisiologia del tessuto adiposo di soggetti obesi con diabete

2020-01-14T12:54:53+01:00

Contributo: Commento editoriale a cura di Angelo Cignarelli e Valentina A. Genchi Il bypass gastrico determina cambiamenti precoci nella fisiologia del tessuto adiposo di soggetti obesi con diabete Breve razionale: la chirurgia

Il bypass gastrico determina cambiamenti precoci nella fisiologia del tessuto adiposo di soggetti obesi con diabete2020-01-14T12:54:53+01:00

Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome.

2020-01-14T12:57:24+01:00

Contributo: Stefania Camastra Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome. ABSTRACT In modelli animali, il Time-Restricted Feeding (TRF) può prevenire e risolvere vari aspetti

Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome.2020-01-14T12:57:24+01:00

Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data

2019-09-13T20:26:31+02:00

Contributo: Valeria Guglielmi Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data Confronto di efficacia

Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data2019-09-13T20:26:31+02:00

Change in thyroid replacement therapy after bariatric surgery: difference between laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy.

2019-09-12T17:55:42+02:00

Contributo: Paola Fierabracci Commento a: Change in thyroid replacement therapy after bariatric surgery: difference between laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. Obes Surg.Epub 2019 Apr 25, Julià H,

Change in thyroid replacement therapy after bariatric surgery: difference between laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy.2019-09-12T17:55:42+02:00

Longer-term liraglutide administration at the highest dose approved for obesity increases reward-related orbitofrontal cortex activations to food cues: Implications for plateauing weight loss in response to anti-obesity therapies.

2019-09-03T23:33:08+02:00

A cura di Stefania Camastra Longer-term liraglutide administration at the highest dose approved for obesity increases reward-related orbitofrontal cortex activations to food cues: Implications for plateauing weight loss in response to anti-obesity therapies. Farr

Longer-term liraglutide administration at the highest dose approved for obesity increases reward-related orbitofrontal cortex activations to food cues: Implications for plateauing weight loss in response to anti-obesity therapies.2019-09-03T23:33:08+02:00

Prenatal Antimicrobic use and Early Chialdhood Body Mass Index

2019-05-29T18:33:46+02:00

Contributo di Maria Angela Guzzardi Prenatal Antimicrobic use and Early Chialdhood Body Mass Index Cassidy-Bushrow AE, Burmeister C, Havstad S Levin AM, Lynch SV, Ownby DR, Rundle AG, Woodcroft KJ, Zoratti EM, Johnson

Prenatal Antimicrobic use and Early Chialdhood Body Mass Index2019-05-29T18:33:46+02:00

Identification of Metabolically Distinct Adipocyte Progenitor Cells in Human Adipose Tissues

2019-05-29T18:31:28+02:00

Contributo di Gianluca Gortan Cappellari Commento a: Identification of Metabolically Distinct Adipocyte Progenitor Cells in Human Adipose Tissues Arthe Raajendiran, Geraldine Ooi, Jackie Bayliss, Paul E. O’Brien, Ralf B.Schittenhelm, Ashlee K. Clark, Renea

Identification of Metabolically Distinct Adipocyte Progenitor Cells in Human Adipose Tissues2019-05-29T18:31:28+02:00

LOGIN SOCI

Torna in cima